Evidence map›Paper›PMID 40879063›Full record

Observational studyJournal of the American Heart Association2025

Noninvasive Hemodynamic Characterization of Cardiohepatic Syndrome in the Cardiac Intensive Care Unit.

Ahsan Butt, Mitchell Padkins, P E Miller, Jason N Katz, Dustin B Hillerson, Drew N Rosenbaum, Marc D Samsky, Maan Jokhadar, Jacob C Jentzer

Abstract readObservational Study
In one paragraph

Observational study in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ahsan ButtDepartment of Internal Medicine Mayo Clinic Rochester MN USA.ORCID 0000-0003-0539-999X
Mitchell PadkinsDepartment of Cardiovascular Medicine Mayo Clinic Rochester MN USA.ORCID 0000-0002-7144-5280
P E MillerSection of Cardiovascular Medicine Yale School of Medicine New Haven CT USA.ORCID 0000-0002-0595-1492
Jason N KatzDivision of Cardiology NYU Grossman School of Medicine & Bellevue Hospital New York NY USA.ORCID 0000-0002-3460-5169
Dustin B HillersonDepartment of Cardiovascular Medicine Mayo Clinic Rochester MN USA.ORCID 0000-0002-9962-8855
Drew N RosenbaumDepartment of Cardiovascular Medicine Mayo Clinic Rochester MN USA.ORCID 0000-0001-9202-0233
Marc D SamskySection of Cardiovascular Medicine Yale School of Medicine New Haven CT USA.ORCID 0000-0001-7524-5174
Maan JokhadarDepartment of Cardiovascular Medicine Mayo Clinic Rochester MN USA.ORCID 0009-0009-0882-2133
Jacob C JentzerDepartment of Cardiovascular Medicine Mayo Clinic Rochester MN USA.ORCID 0000-0002-6366-2859

Funding

Mayo Clinic StARR ProgramR38HL150086 · NHLBI · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC, KARL A. NATH · 2020 to 2026
$2.5M
NHLBI NIH HHS R38 HL150086
6 · The paper itself

Abstract

backgroundPatients with cardiohepatic syndrome are at higher risk of adverse outcomes in the cardiac intensive care unit. We hypothesized that cardiohepatic syndrome phenotypes would exhibit differences in their clinical and transthoracic echocardiogram hemodynamic profiles, portending a higher risk of mortality.

methodsWe included unique CICU patients with an admission diagnosis of heart failure from 2007 to 2018 with available data for 1 or more admission liver function tests. Echocardiographic variables were extracted from patients who had a transthoracic echocardiogram within 1 day of admission. We assigned patients to 1 of 4 mutually exclusive cardiohepatic syndrome phenotype groups: normal, hepatocellular, cholestasis, and combined.

resultsWe included 3992 CICU patients; 2483 had an available transthoracic echocardiogram. Patients with cholestasis had more right ventricular systolic dysfunction and congestion, whereas those with hepatocellular injury had more left ventricular systolic dysfunction and poor forward flow; hemodynamics and biventricular function were worst in the combined group. In-hospital mortality occurred in 14.6% and was higher for patients with cholestasis or hepatocellular injury, especially those with greater extent/severity and worse biventricular function or poor hemodynamics. After adjustment, only the group with hepatocellular injury (adjusted odds ratio [OR], 1.35 [95% CI, 1.04-1.75],

conclusionsCardiohepatic syndrome phenotypes are associated with distinct echocardiographic profiles. Patients with the combined cardiohepatic syndrome phenotype were at highest risk of mortality, particularly if this was combined with poor cardiac function.

Indexed as

CholestasisCoronary Care UnitsHeart FailureHemodynamicsLiver DiseasesAgedAged, 80 and overCritical Care OutcomesEchocardiographyFemaleHeart VentriclesHospital MortalityHumansLiver Function TestsMaleMiddle Agedcardiac intensive care unitechocardiographyheart failurehemodynamicsliver failureliver function testsliver injury

Identifiers

PMID40879063
PMCPMC12553437

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.